Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 343-351 , February 2007

Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2

Received 4 September 2006 ,Revised 24 October 2006 ,Accepted 14 November 2006.

References 

  1. Datta K, Bellacosa A, Chan TO, Tsichlis PN. Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J. Biol. Chem. 1996 (Nov 29);271(48):30835–30839
  2. Neubauer JA. Invited review: physiological and pathophysiological responses to intermittent hypoxia. J. Appl. Physiol. 2001 (Apr);90(4):1593–1599
  3. Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, Beguin P, Godin-Ribuot D, Ribuot C, et al. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J. Appl. Physiol. 2005 (May);98(5):1691–1696
  4. Baguet JP, Hammer L, Levy P, Pierre H, Launois S, Mallion JM, et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest. 2005 (Nov);128(5):3407–3412
  5. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur. Respir. J. 2005 (Mar);25(3):514–520
  6. Lavie L, Lavie P. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med. Hypotheses. 2006;66(6):1069–1073
  7. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005 (Oct 25);112(17):2660–2667
  8. Beguin PC, Joyeux-Faure M, Godin-Ribuot D, Levy P, Ribuot C. Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J. Appl. Physiol. 2005 (Sep);99(3):1064–1069
  9. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 (Nov);74(5):1124–1136
  10. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia–reperfusion injury. Circulation. 2003 (Jul 8);108(1):79–85
  11. Xi L, Tekin D, Gursoy E, Salloum F, Levasseur JE, Kukreja RC. Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am. J. Physiol.: Heart Circ. Physiol. 2002;283(1):H5–H12
  12. Yamashita N, Nishida M, Hoshida S, Kuzuya T, Hori M, Taniguchi N, et al. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J. Clin. Invest. 1994 (Dec);94(6):2193–2199
  13. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br. J. Pharmacol. 1995 (May);115(2):222–224
  14. Kis A, Yellon DM, Baxter GF. Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J. Mol. Cell Cardiol. 2003 (Sep);35(9):1063–1071
  15. Wang Y, Ahmad N, Kudo M, Ashraf M. Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. Am. J. Physiol.: Heart Circ. Physiol. 2004 (Sep);287(3):H1125–H1131
  16. Sugden PH, Clerk A. “Stress-responsive” mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ. Res. 1998 (Aug 24);83(4):345–352
  17. Carroll R, Yellon DM. Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP. Basic Res. Cardiol. 2000 (Jun);95(3):243–249
  18. Lasley RD, Keith BJ, Kristo G, Yoshimura Y, Mentzer RM. Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent. Am. J. Physiol.: Heart Circ. Physiol. 2005 (Aug);289(2):H785–H791
  19. Zhao TC, Hines DS, Kukreja RC. Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels. Am. J. Physiol.: Heart Circ. Physiol. 2001 (Mar);280(3):H1278–H1285
  20. Gong KZ, Zhang ZG, Li AH, Huang YF, Bu P, Dong F, et al. ROS-mediated ERK activation in delayed protection from anoxic preconditioning in neonatal rat cardiomyocytes. Chin. Med. J. (Engl.). 2004 (Mar);117(3):395–400
  21. Fryer RM, Hsu AK, Gross GJ. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res. Cardiol. 2001 (Apr);96(2):136–142
  22. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model?. Circulation. 1995 (Sep 15);92(6):1546–1557
  23. Hanlon PR, Fu P, Wright GL, Steenbergen C, Arcasoy MO, Murphy E. Mechanisms of erythropoietin-mediated cardioprotection during ischemia–reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J. 2005 (Aug);19(10):1323–1325
  24. Gross ER, Peart JN, Hsu AK, Auchampach JA, Gross GJ. Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway. Am. J. Physiol.: Heart Circ. Physiol. 2005 (Jun);288(6):H2744–H2749
  25. Arnaud C, Joyeux-Faure M, Bottari S, Godin-Ribuot D, Ribuot C. New insight into the signalling pathways of heat stress-induced myocardial preconditioning: protein kinase Cepsilon translocation and heat shock protein 27 phosphorylation. Clin. Exp. Pharmacol. Physiol. 2004 (Mar);31(3):129–133
  26. Baxter GF, Mocanu MM, Yellon DM. Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo. J. Mol. Cell Cardiol. 1997 (Jul);29(7):1967–1975
  27. Yu R, Mandlekar S, Tan TH, Kong AN. Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J. Biol. Chem. 2000 (Mar 31);275(13):9612–9619
  28. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizvi A, Zhang J, et al. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J. Clin. Invest. 1998 (May 15);101(10):2182–2198
  29. Light PE, Bladen C, Winkfein RJ, Walsh MP, French RJ. Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc. Natl. Acad. Sci. U. S. A. 2000 (Aug 1);97(16):9058–9063
  30. Nayeem MA, Mustafa SJ. Mechanisms of delayed preconditioning with A1 adenosine receptor activation in porcine coronary smooth muscle cells. Pol. J. Pharmacol. 2002 (Sep–Oct);54(5):443–453
  31. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell Cardiol. 2001 (Nov);33(11):1897–1918
  32. Yang XM, Sato H, Downey JM, Cohen MV. Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. J. Mol. Cell Cardiol. 1997 (Mar);29(3):991–999
  33. Crisostomo PR, Wairiuko GM, Wang M, Tsai BM, Morrell ED, Meldrum DR. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J. Am. Coll. Surg. 2006 (May);202(5):797–812
  34. Qin Q, Downey JM, Cohen MV. Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am. J. Physiol.: Heart Circ. Physiol. 2003 (Feb);284(2):H727–H734
  35. Germack R, Dickenson JM. Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes. J. Mol. Cell Cardiol. 2005 (Sep);39(3):429–442
  36. Kulisz A, Chen N, Chandel NS, Shao Z, Schumacker PT. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am. J. Physiol.: Lung Cell Mol. Physiol. 2002 (Jun);282(6):L1324–L1329
  37. Zheng M, Reynolds C, Jo SH, Wersto R, Han Q, Xiao RP. Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury. FASEB J. 2005 (Jan);19(1):109–111
  38. Dana A, Skarli M, Papakrivopoulou J, Yellon DM. Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ. Res. 2000 (May 12);86(9):989–997
  39. Clerk A, Sugden PH. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett. 1998 (Apr 10);426(1):93–96
  40. Ping P, Murphy E. Role of p38 mitogen-activated protein kinases in preconditioning: a detrimental factor or a protective kinase?. Circ. Res. 2000 (May 12);86(9):921–922
  41. Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, et al. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J. 2000 (Nov);14(14):2237–2246
  42. Tanno M, Bassi R, Gorog DA, Saurin AT, Jiang J, Heads RJ, et al. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ. Res. 2003 (Aug 8);93(3):254–261

PII: S0022-2828(06)01028-5

doi: 10.1016/j.yjmcc.2006.11.008

Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 343-351 , February 2007

Article Tools

* Image Usage & Resolution